AMENDED AND RESTATED CLINICAL DEVELOPMENT AND LICENSE AGREEMENTClinical Development and License Agreement • March 16th, 2017 • Biodelivery Sciences International Inc • Pharmaceutical preparations • New York
Contract Type FiledMarch 16th, 2017 Company Industry Jurisdiction
TERMINATION AGREEMENTTermination Agreement • March 16th, 2017 • Biodelivery Sciences International Inc • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 16th, 2017 Company Industry JurisdictionThis Termination Agreement (the “Termination Agreement”), is dated as of December 7, 2016 (the “Effective Date”), by and among Arius Pharmaceuticals, Inc., a Delaware corporation (“Arius”), Arius Two, Inc., a Delaware corporation (“Arius Two”), BioDelivery Sciences International, Inc., a Delaware corporation (“Parent” and, together with Arius and Arius Two, collectively, “BDSI”), and Endo Pharmaceuticals Inc., a Delaware corporation (“Endo” and together with BDSI, the “Parties”, and each, a “Party”).